Loading your page…
Loading your page…
Published by Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and Spanish Society of Thoracic Surgeons (SECT) [2]
Accurate mediastinal nodal staging is essential for the management of non-small cell lung cancer (NSCLC), as it refines prognosis, guides multimodal treatment, and improves survival [2]. This joint consensus document updates and expands the 2011 SEPAR guidelines, incorporating the 9th edition of the TNM classification [2].
Key Takeaways
This joint consensus document from SEPAR and SECT updates and expands the 2011 SEPAR guidelines, incorporating the 9th edition of the TNM classification and extending recommendations to the entire perioperative setting, including both preoperative and intraoperative mediastinal staging. [1]
Invasive mediastinal staging is not required for T1a and T1b tumours without radiological evidence of nodal disease, regardless of their location. [1]
Particular attention is given to the role of N1 disease, which is recognized as a setting associated with a high risk of unsuspected mediastinal involvement. [1]
For cases with intermediate suspicion of mediastinal disease, surgical staging techniques demonstrate superior accuracy compared with endosonography alone. [1]
Clinical Topic
Perioperative Invasive Mediastinal Staging of Non-small Cell Lung Cancer [1, 2]
Objectives
To update and expand the 2011 SEPAR guidelines, incorporating the 9th edition of the TNM classification and extending recommendations to the entire perioperative setting, including both preoperative and intraoperative mediastinal staging [2].
Target Patient Population
Patients with non-small cell lung cancer (NSCLC) undergoing perioperative staging [1, 2].
Target Providers
Therapeutic Area
OncologyGuideline Scope
Care Settings
Difficulty
advanced
Learning Paths